We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+8.45%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$4.45B
AUM Growth
+$284M
Cap. Flow
-$20.5M
Cap. Flow %
-0.46%
Top 10 Hldgs %
34.33%
Holding
1,079
New
59
Increased
179
Reduced
284
Closed
85

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$30M
2
CVS icon
CVS Health
CVS
+$24.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$16.5M
4
UNH icon
UnitedHealth
UNH
+$14.5M
5
NVDA icon
NVIDIA
NVDA
+$6.26M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Healthcare 16.06%
3 Financials 12.32%
4 Consumer Discretionary 10.19%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.8T
$319M 7.17%
1,646,593
-1,984
-0.1% -$346K
MSFT icon
2
Microsoft
MSFT
$2.99T
$259M 5.81%
759,620
-13,735
-2% -$4.3M
AVGO icon
3
Broadcom
AVGO
$1.8T
$163M 3.67%
1,883,940
-61,440
-3% -$4.38M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.29T
$148M 3.33%
1,226,787
+762
+0.1% +$88.2K
JNJ icon
5
Johnson & Johnson
JNJ
$599B
$136M 3.05%
819,678
+1,051
+0.1% +$170K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$133M 2.99%
390,534
-6,406
-2% -$2.09M
HD icon
7
Home Depot
HD
$332B
$105M 2.35%
336,876
+7,237
+2% +$2.14M
MCD icon
8
McDonald's
MCD
$190B
$92.2M 2.07%
309,066
-2,610
-0.8% -$758K
MA icon
9
Mastercard
MA
$484B
$88.3M 1.98%
224,452
+6,697
+3% +$2.51M
LRCX icon
10
Lam Research
LRCX
$384B
$85.2M 1.91%
1,325,130
-24,190
-2% -$1.36M
LHX icon
11
L3Harris
LHX
$52.3B
$84.9M 1.91%
433,681
-2,047
-0.5% -$392K
ACN icon
12
Accenture
ACN
$88.6B
$82.3M 1.85%
266,751
-7,705
-3% -$2.24M
CDW icon
13
CDW
CDW
$16.6B
$81.7M 1.83%
445,144
+4,533
+1% +$792K
V icon
14
Visa
V
$686B
$80.8M 1.81%
340,281
+12,303
+4% +$2.82M
TMO icon
15
Thermo Fisher Scientific
TMO
$196B
$75.6M 1.7%
144,865
+2,513
+2% +$1.36M
UNH icon
16
UnitedHealth
UNH
$383B
$73M 1.64%
151,829
-29,723
-16% -$14.5M
ABBV icon
17
AbbVie
ABBV
$448B
$72.4M 1.63%
537,295
+12,553
+2% +$1.84M
AME icon
18
Ametek
AME
$53.9B
$70.1M 1.57%
433,046
+12,633
+3% +$1.85M
AMZN icon
19
Amazon
AMZN
$2.69T
$70M 1.57%
536,937
-1,949
-0.4% -$223K
BSCN
20
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$66.3M 1.49%
3,129,446
+5,504
+0.2% +$116K
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$4.3T
$66M 1.48%
551,255
+348
+0.1% +$40.1K
CVX icon
22
Chevron
CVX
$378B
$65.7M 1.48%
417,737
+8,856
+2% +$1.42M
AON icon
23
Aon
AON
$77.5B
$64.3M 1.44%
186,209
-6,833
-4% -$2.22M
RTX icon
24
RTX Corp
RTX
$262B
$62.9M 1.41%
642,111
-148
-0% -$14.5K
SPGI icon
25
S&P Global
SPGI
$133B
$56.8M 1.28%
141,780
+1,708
+1% +$624K

Similar funds

HM Payson & Co's Q2 2023 Portfolio in Review

As of Q2 2023, HM Payson & Co held 1,079 positions worth $4.45B, up 6.8% from $4.17B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

HM Payson & Co's Q2 2023 filing shows 59 new, 179 increased, 284 reduced and 85 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M. The largest sale was Pfizer, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q2 2023 buy was iShares iBonds Dec 2024 Term Corporate ETF: 123,835 shares worth $3.05M.
  • HM Payson & Co added most to Marathon Petroleum in Q2 2023, an estimated $41.1M increase.
  • HM Payson & Co's biggest Q2 2023 reduction was Pfizer, cutting an estimated $30M.
  • HM Payson & Co fully exited Vanguard Short-Term Bond ETF in Q2 2023, selling an estimated $3.44M.
  • HM Payson & Co's ten largest holdings make up 34% of its $4.45B portfolio in Q2 2023.
  • HM Payson & Co opened 59 new positions and closed 85 in Q2 2023.
  • HM Payson & Co's portfolio value rose 6.8% quarter-over-quarter to $4.45B.

Based on HM Payson & Co's 13F filing for Q2 2023, filed 17 Jul 2023.